Atlas of Neuromuscular Diseases (3^rd Ed., 3rd ed. 2021)
A Practical Guideline

This atlas offers a comprehensive overview of neuromuscular diseases. It discusses all aspects of neuromuscular disorders, including general tools, the cranial and spinal nerves, the nerve plexus, peripheral nerves, mono- and polyneuropathies, entrapment syndromes, the neuromuscular junction, motor neuron diseases, muscle disease, and autonomic involvement.

Each chapter is structured into the following sections: anatomy, symptoms, signs, pathogenesis, diagnosis and differential diagnosis, therapy, and prognosis. The diagnostic tools used for neuromuscular disease are explained, and the therapeutic options for each disease are described. 

This updated third edition includes new chapters addressing a range of topics: from histology to molecular mechanisms, genetic aspects, the mechanisms of emerging new therapies, neuroimaging, neuromuscular disease, and new pathogenic mechanisms.

The book aims to be a useful companion for neuromuscular disease. The homogenous structure, illustrations with figures, and representative images makes the atlas easy to read and helpful in understanding neuromuscular problems.

Dr. Eva Feldman is a clinician-scientist who has devoted her career towards understanding the neurological complications of obesity and diabetes, uncovering the pathogenesis of neurodegenerative diseases, improving treatment options for patients, and educating health care professionals. With over 30 years of continuous funding from the National Institutes of Health (NIH), her reputation is internationally recognized and she directs a research program of 22 scientists at the University of Michigan Medicine. In the laboratory, her pioneering studies on neurological disorders in metabolic diseases using cell-based models, novel mouse models, and human subjects has identified dyslipidemia during obesity and diabetes as a key driver of nervous system damage in children and adults, leading to new clinical guidelines on patient care by the American Diabetes Association (ADA). Her comprehensive transcriptomic, proteomic, and metabolomic phenotyping of obese and diabetic animal models and human samples is likewise furthering insight into the pathogenesis of neurological complications and driving the development of novel therapies. Dr. Feldman is also a pioneer in translating laboratory discoveries into clinical treatments, and served as the Principal Investigator of the first two FDA approved clinical trials evaluating a stem cell transplantation therapy for amyotrophic lateral sclerosis (ALS). These advances are complemented by her research efforts focused on understanding the role environmental exposures and the immune system play in ALS. Dr. Feldman’s findings are published in 450 manuscripts, 70 book chapters, and 4 books, and she has trained over 100 basic science and clinical fellows. She directed the A. Alfred Taubman Medical Research Institute at the University of Michigan from 2007 to 2017, and received $100 million in 2011 to support translational research in the Institute by clinician-scientists. She served as President of the American Neurological Asso

Offers a quick and easy overview of the most common neuromuscular diseases, thanks to its clear structure and outline approach

A wealth of photos and illustrations help readers understand the basic mechanisms and diagnostic results for neuromuscular disorders

Written by experienced authors from Europe and the US